Stryker Corporation (SYK) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Stryker Corporation · Health Care · ref. ETF XLV · 74 calls · price $322.12
What the company does: Stryker Corporation operates as a medical technology company in the United States and internationally.
📈 Stryker Corporation (SYK) stock price
$322.12-17.3% over range
Aug 28, 25low $282.58 · high $394.34Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
76% recommend buying · 17 analysts
📊 JPI status : Stryker Corporation has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 SYK price target & analyst consensus — price $322
The price target · all analysts combined (16 targets)
Highest target · 1 firm of 16$420+30.4%
Median target · of 16 targets$387.5+20.3%
Lowest target · 1 firm of 16$340+5.6%
Current price$322.12
Where these 16 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
16100%
$340 ↔ $420
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: BMO Capital — 73% of its targets hit on this sector (239 calls tested). It aims for $369 (+15 %), call made on July 10, 2026, maturing on July 10, 2027 (49 d ago).
The 6 reliable analysts
$364+13 %
The 10 other firms
$397+23 %
How to read it: the 6 reliable firms are not filtered by optimism — 6 aim above the price, 0 below, hence their $364 median. “The 10 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 17 ratings (last 6 months)
Strong Buy00%
Buy1376%
Hold424%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 SYK price target all
All 74 calls, one by one, with our verdict on each firm.
→ See all 74 targets, analyst by analyst💡 The best analysts on SYK most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in SYK? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Stryker Corporation? The JPI assistant answers using our backtest data.
💰 Stryker Corporation dividend: yield, history & growth › open the full page
1.11%annual yield
📈 Steady dividend — 16 yrs of consecutive dividend increases
That's ~$3.48 per share per year.
📈 Stryker Corporation fundamentals: valuation, margins & growth › open the full page
P/E 34.1Net margin 14.4 %Revenue growth +9.4 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 13 %
2023
Rev +11%Profit +34%
2024
Rev +10%Profit −5%
2025
Rev +11%Profit +8%
🔎 Detailed analyses
🏛️ Which US Congress members hold Stryker Corporation (SYK)?
5 Congress members have disclosed SYK buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Cindy Axne 3× · 57%Gilbert Cisneros 1× · 48%Michael Burgess 1× · 40%Rick Larsen 1×Greg Stanton 1× · 48%
✅ Historical analyst reliability on SYK
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| UBS ↗ | 100% | +35.0% | 2 |
| B of A Securities ↗ | 100% | +26.6% | 2 |
| Argus Research ↗ | 100% | +24.9% | 5 |
| Jefferies ↗ | 100% | +19.2% | 3 |
| Deutsche Bank ↗ | 100% | +18.6% | 6 |
| Bernstein ↗ | 100% | +13.5% | 2 |
| BTIG ↗ | 93% | +17.9% | 15 |
| Stifel ↗ | 87% | +18.7% | 15 |
| Roth MKM | 80% | +16.7% | 5 |
| Raymond James ↗ | 80% | +16.7% | 5 |
See the other 16 firms
| Evercore ISI Group ↗ | 38% | +0.8% | 8 |
| Leerink Swann | 50% | +3.8% | 2 |
| Barclays ↗ | 56% | +2.7% | 16 |
| Needham ↗ | 56% | +2.9% | 9 |
| Canaccord Genuity ↗ | 56% | +8.3% | 16 |
| JP Morgan ↗ | 62% | +12.5% | 8 |
| Morgan Stanley ↗ | 65% | +12.0% | 17 |
| Loop Capital ↗ | 67% | +10.1% | 3 |
| Citigroup ↗ | 67% | +16.7% | 15 |
| Wells Fargo ↗ | 69% | +16.9% | 16 |
| Piper Sandler ↗ | 73% | +12.8% | 11 |
| RBC Capital ↗ | 75% | +9.3% | 16 |
| SVB Leerink | 75% | +13.8% | 4 |
| Credit Suisse | 75% | +16.2% | 12 |
| Goldman Sachs ↗ | 80% | +0.3% | 5 |
| Baird ↗ | 80% | +7.9% | 10 |
📊 What $1,000 invested in Stryker Corporation would be worth › open the full page
In short — $1,000 invested in Stryker Corporation 10 years ago would be worth $3,152 today, i.e. +12%/yr on average. Best year: 2023 (+33%), worst: 2022 (0%). Price performance, excluding dividends.
If I'd invested $1,000 in Stryker Corporation
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $815 | -18% |
| 3 years ago | $1,198 | +20% |
| 5 years ago | $1,297 | +30% |
Return by year (Stryker Corporation)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -19% | $813 (-19%) |
| 2025 | +0% | $815 (-18%) |
| 2024 | +11% | $902 (-10%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Stryker Corporation
Loading news…
📋 All analyst calls on SYK
Filtered on — · ✕ show all
Wolfe Research ↗
Aug 13, 26
■ Peer Perform neutral · not a buy
🎯 on SYK : no call matured yet · 📊 on Health : 60.9% · +4.3% (46 calls)
in progress (365j)
matures : Aug 13, 27
matures : Aug 13, 27
Citizens
Aug 3, 26
▲ Market Outperform · 🎯$400
Price at call : $335.96 — upside +19%
Today : $322.12 — upside +24%
🎯 on SYK : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Aug 3, 27
matures : Aug 3, 27
RBC Capital ↗
Jul 31, 26
▲ Outperform · 🎯$420
Price at call : $341.2 — upside +23%
Today : $322.12 — upside +30%
🎯 on SYK : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
▲ Overweight · 🎯$350
Price at call : $341.2 — upside +3%
Today : $322.12 — upside +9%
🎯 on SYK : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Piper Sandler ↗
Jul 31, 26
▲ Overweight · 🎯$390
Price at call : $341.2 — upside +14%
Today : $322.12 — upside +21%
🎯 on SYK : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
Truist Securities ↗
Jul 31, 26
■ Hold neutral · not a buy · 🎯$340
Price at call : $325.7 — gap to target +4%
Today : $322.12 — gap to target +6%
🎯 on SYK : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
▲ Buy · 🎯$358
Price at call : $325.7 — upside +10%
Today : $322.12 — upside +11%
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Jul 31, 27
matures : Jul 31, 27
BMO Capital ↗
Jul 9, 26
▲ Outperform · 🎯$369
Price at call : $329.78 — upside +12%
Today : $322.12 — upside +15%
🎯 on SYK : no call matured yet · 📊 on Health : 60.7% · +8.8% (239 calls)
in progress (365j)
matures : Jul 9, 27
matures : Jul 9, 27
See the other 66 calls, newest to oldest
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$350
Price at call : $329.74 — upside +6%
Today : $322.12 — upside +9%
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
Leerink Partners ↗
Jun 5, 26
▲ Outperform · 🎯$407
Price at call : $305.66 — upside +33%
Today : $322.12 — upside +26%
🎯 on SYK : no call matured yet · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : Jun 5, 27
matures : Jun 5, 27
Truist Securities ↗
May 4, 26
■ Hold neutral · not a buy · 🎯$330
Price at call : $295.25 — gap to target +12%
Today : $322.12 — gap to target +2%
🎯 on SYK : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : May 4, 27
matures : May 4, 27
▲ Overweight · 🎯$394
Price at call : $295.25 — upside +33%
Today : $322.12 — upside +22%
🎯 on SYK : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : May 4, 27
matures : May 4, 27
Canaccord Genuity ↗
May 2, 26
▲ Buy · 🎯$400
Price at call : $290.88 — upside +38%
Today : $322.12 — upside +24%
🎯 on SYK : 42% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
in progress (365j)
matures : May 2, 27
matures : May 2, 27
▲ Overweight · 🎯$400
Price at call : $290.88 — upside +38%
Today : $322.12 — upside +24%
🎯 on SYK : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
Evercore ISI Group ↗
May 1, 26
▲ Outperform · 🎯$355
Price at call : $290.88 — upside +22%
Today : $322.12 — upside +10%
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
Wells Fargo ↗
May 1, 26
▲ Overweight · 🎯$418
Price at call : $290.88 — upside +44%
Today : $322.12 — upside +30%
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
▲ Buy · 🎯$418
Price at call : $294.73 — upside +42%
Today : $322.12 — upside +30%
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
▲ Buy · 🎯$379
Price at call : $294.73 — upside +29%
Today : $322.12 — upside +18%
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : May 1, 27
matures : May 1, 27
Truist Securities ↗
Apr 15, 26
■ Hold neutral · not a buy · 🎯$380
Price at call : $338.38 — gap to target +12%
Today : $322.12 — gap to target +18%
🎯 on SYK : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Apr 15, 27
matures : Apr 15, 27
▲ Buy · 🎯$397
Price at call : $345.88 — upside +15%
Today : $322.12 — upside +23%
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Apr 14, 27
matures : Apr 14, 27
Leerink Partners ↗
Apr 13, 26
▲ Outperform · 🎯$410
Price at call : $347.24 — upside +18%
Today : $322.12 — upside +27%
🎯 on SYK : no call matured yet · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
Goldman Sachs ↗
Apr 9, 26
■ Neutral neutral · not a buy · 🎯$357
Price at call : $339.15 — gap to target +5%
Today : $322.12 — gap to target +11%
🎯 on SYK : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Apr 9, 27
matures : Apr 9, 27
▲ Buy · 🎯$385
Price at call : $340.01 — upside +13%
Today : $322.12 — upside +20%
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Apr 7, 27
matures : Apr 7, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$365
Price at call : $332.07 — upside +10%
Today : $322.12 — upside +13%
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
■ Neutral neutral · not a buy · 🎯$380
Price at call : $345.81 — gap to target +10%
Today : $322.12 — gap to target +18%
🎯 on SYK : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Mar 17, 27
matures : Mar 17, 27
■ Neutral neutral · not a buy · 🎯$400
Price at call : $384.03 — gap to target +4%
Today : $322.12 — gap to target +24%
🎯 on SYK : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
▲ Overweight · 🎯$469
Price at call : $360.82 — upside +30%
Today : $322.12 — upside +46%
🎯 on SYK : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
▲ Buy · 🎯$454
Price at call : $369.56 — upside +23%
Today : $322.12 — upside +41%
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Jan 30, 27
matures : Jan 30, 27
▲ Buy · 🎯$412
Price at call : $369.56 — upside +11%
Today : $322.12 — upside +28%
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Jan 30, 27
matures : Jan 30, 27
▲ Outperform · 🎯$465
Price at call : $361.37 — upside +29%
Today : $322.12 — upside +44%
🎯 on SYK : no call matured yet · 📊 on Health : 54.7% · +5.2% (64 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
Citizens
Dec 19, 25
▲ Market Outperform · 🎯$440
Price at call : $355.2 — upside +24%
Today : $322.12 — upside +37%
🎯 on SYK : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Dec 19, 26
matures : Dec 19, 26
Truist Securities ↗
Dec 18, 25
■ Hold neutral · not a buy · 🎯$392
Price at call : $355.2 — gap to target +10%
Today : $322.12 — gap to target +22%
🎯 on SYK : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Dec 18, 26
matures : Dec 18, 26
▲ Buy · 🎯$420
Price at call : $354.09 — upside +19%
Today : $322.12 — upside +30%
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Dec 11, 26
matures : Dec 11, 26
Truist Securities ↗
Nov 14, 25
■ Hold neutral · not a buy · 🎯$400
Price at call : $360.13 — gap to target +11%
Today : $322.12 — gap to target +24%
🎯 on SYK : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Nov 14, 26
matures : Nov 14, 26
Wells Fargo ↗
Nov 14, 25
▲ Overweight · 🎯$456
Price at call : $360.13 — upside +27%
Today : $322.12 — upside +42%
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Nov 14, 26
matures : Nov 14, 26
▲ Buy · 🎯$448
Price at call : $362.22 — upside +24%
Today : $322.12 — upside +39%
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 50.3% · +4.1% (155 calls)
in progress (365j)
matures : Nov 14, 26
matures : Nov 14, 26
▲ Buy · 🎯$410
Price at call : $362.22 — upside +13%
Today : $322.12 — upside +27%
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Nov 14, 26
matures : Nov 14, 26
Truist Securities ↗
Nov 3, 25
■ Hold neutral · not a buy · 🎯$392
Price at call : $362.61 — gap to target +8%
Today : $322.12 — gap to target +22%
🎯 on SYK : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Nov 3, 26
matures : Nov 3, 26
Evercore ISI Group ↗
Oct 31, 25
▲ Outperform · 🎯$405
Price at call : $358.16 — upside +13%
Today : $322.12 — upside +26%
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
▲ Buy · 🎯$410
Price at call : $356.24 — upside +15%
Today : $322.12 — upside +27%
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
▲ Overweight · 🎯$453
Price at call : $383.06 — upside +18%
Today : $322.12 — upside +41%
🎯 on SYK : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Oct 22, 26
matures : Oct 22, 26
Truist Securities ↗
Oct 15, 25
■ Hold neutral · not a buy · 🎯$407
Price at call : $369.25 — gap to target +10%
Today : $322.12 — gap to target +26%
🎯 on SYK : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Oct 15, 26
matures : Oct 15, 26
▲ Buy · 🎯$408
Price at call : $364.92 — upside +12%
Today : $322.12 — upside +27%
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Oct 13, 26
matures : Oct 13, 26
Evercore ISI Group ↗
Oct 7, 25
▲ Outperform · 🎯$410
Price at call : $375.29 — upside +9%
Today : $322.12 — upside +27%
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Oct 7, 26
matures : Oct 7, 26
Rothschild & Co
Sep 18, 25
■ Neutral neutral · not a buy · 🎯$420
Price at call : $376.83 — gap to target +11%
Today : $322.12 — gap to target +30%
🎯 on SYK : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Sep 18, 26
matures : Sep 18, 26
Truist Securities ↗
Aug 4, 25
■ Hold neutral · not a buy · 🎯$415
Price at call : $381.49 — gap to target +9%
Today : $322.12 — gap to target +29%
🎯 on SYK : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Aug 4, 26
matures : Aug 4, 26
Wells Fargo ↗
Aug 1, 25
▲ Overweight · 🎯$445
Price at call : $381.49 — upside +17%
Today : $322.12 — upside +38%
Expected +17% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 48.5% · +1.2% (392 calls)
-10.6%
stock -11% · XLV +22%
matured Aug 1, 26
▲ Buy · 🎯$448
Price at call : $377.79 — upside +19%
Today : $322.12 — upside +39%
Expected +19% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 50.3% · +4.1% (155 calls)
-9.7%
stock -10% · XLV +24%
matured Aug 1, 26
Evercore ISI Group ↗
Jul 8, 25
▲ Outperform · 🎯$415
Price at call : $389.5 — upside +7%
Today : $322.12 — upside +29%
Expected +7% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 45.8% · +0.0% (168 calls)
-16.1%
stock -16% · XLV +20%
matured Jul 8, 26
▲ Buy · 🎯$455
Price at call : $376.62 — upside +21%
Today : $322.12 — upside +41%
Expected +21% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 0% (1 call matured) · 📊 on Health : 53.1% · +2.5% (508 calls)
-16.9%
stock -17% · XLV +14%
matured May 22, 26
Canaccord Genuity ↗
Jan 29, 25
▲ Buy · 🎯$435
Price at call : $391.07 — upside +11%
Today : $322.12 — upside +35%
Expected +11% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 42% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
-9.4%
stock -9% · XLV +6%
matured Jan 29, 26
▲ Buy · 🎯$394
Price at call : $356.28 — upside +11%
Today : $322.12 — upside +22%
Expected +11% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
-0.0%
stock -0% · XLV -2%
matured Oct 30, 25
Canaccord Genuity ↗
Oct 30, 24
▲ Buy · 🎯$400
Price at call : $356.28 — upside +12%
Today : $322.12 — upside +24%
Expected +12% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 42% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
-0.0%
stock -0% · XLV -2%
matured Oct 30, 25
▲ Buy · 🎯$383
Price at call : $358.98 — upside +7%
Today : $322.12 — upside +19%
Expected +7% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+3.0%
stock +3% · XLV -7%
matured Oct 14, 25
▲ Buy · 🎯$374
Price at call : $357.93 — upside +4%
Today : $322.12 — upside +16%
Expected +4% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+9.3%
stock +9% · XLV -12%
matured Aug 28, 25
▲ Buy · 🎯$360
Price at call : $333.17 — upside +8%
Today : $322.12 — upside +12%
Expected +8% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+13.4%
stock +13% · XLV -13%
matured Jul 31, 25
▲ Buy · 🎯$372
Price at call : $333.43 — upside +12%
Today : $322.12 — upside +15%
Expected +12% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+17.2%
stock +17% · XLV -10%
matured Jul 15, 25
▲ Buy · 🎯$369
Price at call : $328.12 — upside +12%
Today : $322.12 — upside +15%
Expected +12% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+14.0%
stock +14% · XLV -3%
matured May 1, 25
Canaccord Genuity ↗
Jan 31, 24
▲ Buy · 🎯$360
Price at call : $340.56 — upside +6%
Today : $322.12 — upside +12%
Expected +6% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 42% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+14.9%
stock +15% · XLV +3%
matured Jan 30, 25
▲ Buy · 🎯$313
Price at call : $293.89 — upside +7%
Today : $322.12 — upside -3%
Expected +7% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+11.7%
stock +12% · XLV +5%
matured May 1, 24
▲ Buy · 🎯$299
Price at call : $290.92 — upside +3%
Today : $322.12 — upside -7%
Expected +3% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+15.5%
stock +16% · XLV +4%
matured Apr 16, 24
▲ Buy · 🎯$281
Price at call : $278.95 — upside +1%
Today : $322.12 — upside -13%
Expected +1% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+22.1%
stock +22% · XLV +6%
matured Feb 1, 24
▲ Buy · 🎯$232
Price at call : $214.92 — upside +8%
Today : $322.12 — upside -28%
Expected +8% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+25.7%
stock +26% · XLV +3%
matured Oct 17, 23
▲ Buy · 🎯$238
Price at call : $202.73 — upside +17%
Today : $322.12 — upside -26%
Expected +17% · Actual +43% · Reason (≥ +15%) : ✓ Yes
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+42.6%
stock +43% · XLV +5%
matured Sep 6, 23
▲ Buy · 🎯$244
Price at call : $197.3 — upside +24%
Today : $322.12 — upside -24%
Expected +24% · Actual +49% · Reason (≥ +15%) : ✓ Yes
🎯 on SYK : 92% (12 calls matureds) · 📊 on Health : 54.8% · +8.3% (115 calls)
+49.3%
stock +49% · XLV +2%
matured Jul 18, 23
Canaccord Genuity ↗
Jul 28, 21
▲ Buy · 🎯$290
Price at call : $269.18 — upside +8%
Today : $322.12 — upside -10%
Expected +8% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 42% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
-20.2%
stock -20% · XLV +0%
matured Jul 28, 22
Canaccord Genuity ↗
Apr 28, 21
▲ Buy · 🎯$285
Price at call : $263.43 — upside +8%
Today : $322.12 — upside -12%
Expected +8% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 42% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
-8.4%
stock -8% · XLV +7%
matured Apr 28, 22
Canaccord Genuity ↗
Oct 30, 20
▲ Buy · 🎯$234
Price at call : $202.78 — upside +15%
Today : $322.12 — upside -27%
Expected +15% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on SYK : 42% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+32.4%
stock +32% · XLV +29%
matured Oct 30, 21
Canaccord Genuity ↗
Oct 30, 19
▲ Buy · 🎯$240
Price at call : $216.27 — upside +11%
Today : $322.12 — upside -25%
Expected +11% · Actual -7% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 42% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
-6.6%
stock -7% · XLV +7%
matured Oct 29, 20
Canaccord Genuity ↗
Jul 26, 19
▲ Buy · 🎯$233
Price at call : $214.45 — upside +9%
Today : $322.12 — upside -28%
Expected +9% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 42% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
-8.0%
stock -8% · XLV +15%
matured Jul 25, 20
Canaccord Genuity ↗
Apr 24, 19
▲ Buy · 🎯$195
Price at call : $185.04 — upside +5%
Today : $322.12 — upside -39%
Expected +5% · Actual -1% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 42% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
-1.4%
stock -1% · XLV +13%
matured Apr 23, 20
Canaccord Genuity ↗
Apr 27, 18
▲ Buy · 🎯$185
Price at call : $169.42 — upside +9%
Today : $322.12 — upside -43%
Expected +9% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 42% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+10.5%
stock +11% · XLV +8%
matured Apr 27, 19
Canaccord Genuity ↗
Oct 27, 17
▲ Buy · 🎯$162
Price at call : $155.37 — upside +4%
Today : $322.12 — upside -50%
Expected +4% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on SYK : 42% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+4.1%
stock +4% · XLV +8%
matured Oct 27, 18
Canaccord Genuity ↗
Aug 24, 17
▲ Buy · 🎯$155
Price at call : $139.88 — upside +11%
Today : $322.12 — upside -52%
Expected +11% · Actual +22% · Reason (≥ +15%) : ✓ Yes
🎯 on SYK : 42% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+21.9%
stock +22% · XLV +17%
matured Aug 24, 18
Frequently asked questions
Should I buy Stryker Corporation stock?
This isn't buy advice. For Stryker Corporation, the analyst consensus is "Buy", with an average price target of $388 (+20% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Stryker Corporation). We show the numbers — you decide.
Is it too late to buy Stryker Corporation? How high can it go?
The most bullish analyst target on Stryker Corporation is $420 (+30% above today's price); the average is $388. That's the upside they see. Check how reliable those analysts have actually been on Stryker Corporation on our site before trusting it.
Is Stryker Corporation still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 26 analysts have a real record on Stryker Corporation, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Stryker Corporation? The case for and against
The arguments for and against, one by one, from the numbers: why invest in SYK (and why hesitate).
What has Stryker Corporation's past performance been?
Historical returns and a "how much if I had invested" calculator: SYK performance & returns.
Does Stryker Corporation pay a dividend?
Yield, consistency and growth history of the dividend: SYK's dividend.
What is the best month to buy SYK?
The 12 months ranked by the stock's past returns: best & worst month to buy SYK.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX